The Vaccine Race: Innovations and Insights

This chapter explores the groundbreaking development of COVID-19 vaccines, focusing on the mRNA-1273 candidate by Moderna. It highlights the challenges of conducting vaccine trials during a pandemic and how innovative approaches have expedited the vaccine creation process. The discussion also examines the implications for future medical research funding and the potential shift in vaccine development methodologies.